ISB News

What’s the Secret to ‘Extreme Longevity’?

3 Bullets:

  • ISB researchers and their collaborators studied a group of supercentenarians (110 years or older) to explore the genetics of ‘extreme longevity.’
  • The group performed whole-genome sequencing on 17 supercentenarians in order to look for any rare protein-altering variants associated with extreme longevity.
  • While the researchers did not find a single cause for extreme longevity within this sample size, the genomic data is now available for future studies.

By ISBUSA

The secret to “extreme longevity” is still a secret.

Title: Whole-Genome Sequencing of the World’s Oldest People
Journal: PLOS ONE
Authors: Hinco J. Gierman, Kristen Fortney, Jared C. Roach, Natalie S. Coles, Hong Li, Gustavo Glusman, Glenn J. Markov, Justin D. Smith, Leroy Hood, L. Stephen Coles, Stuart K. Kim
Link: Read the study
Quote: “Supercentenarians (110 years or older) are the world’s oldest people. Seventy four are alive worldwide, with twenty two in the United States.”

ISB researchers in the Family Genomics Group and their collaborators at Standford University, University of California Los Angeles, and the Gerontology Research Group in Los Angeles, studied a group of 17 supercentenarians (110 years or older) in hopes of discovering the genetic basis for their extreme longevity. The researchers performed whole genome sequencing of the participants in order to look for significant enrichment of rare protein-altering variants.

The results ultimately showed no significant evidence of a single cause for extreme longevity – at least not within the sample size of 17. One point of interest was that one of the supercentenarians carried a variant considered to be highly pathogenic; a variant that according to recommendations from the American College of Medical Genetics must be reported if found in someone’s genome. But this variant clearly didn’t cause any disease in this individual.

The data from the study, which includes the DNA sequences and the list of rare protein-altering variants of the 17 supercentenarians, is now available for future research on extreme longevity.

 

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.